Merck & Co. has recalled all lots of its cholesterol drug Liptruzet in the U.S. and Puerto Rico due to packaging defects that could affect the drug’s efficacy. According to the company, the outer foil packaging surrounding the Liptruzet tablets may allow air and moisture to come into contact with the drug, which could affect its efficacy and physical characteristics. Merck maintained that it had not received any adverse event reports or quality complaints that sparked the voluntary recall decision. The recall will completely deplete wholesalers’ supply of Liptruzet in the U.S. and Puerto Rico, according to Merck. However, patients can still obtain the drug’s active ingredients via Merck’s branded drug Zetia and the generic drug atorvastatin.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.